World demand for enzymes will grow 7.6 percent annually through 2011. Gains will be driven by continued robust growth in pharmaceutical enzyme demand, double-digit increases in demand for biocatalysts for drug and fine chemical production, and the rapid expansion in bioethanol production from grains.
This study analyzes the $4.1 billion world enzyme industry. It presents historical demand data for the years 1996, 2001 and 2006 and forecasts for 2011 and 2016 by product (e.g., carbohydrases, proteases, polymerases and nucleases, lipases); market (e.g., industrial, specialty); world region (e.g., North America, Western Europe, Asia/Pacific); and for 15 major national markets.
The study also considers market environment factors, details industry structure, evaluates company market share and profiles 43 major players including Novozymes, Danisco, Genzyme, Roche, Roche, Allergan, DSM, and BASF.